BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Semb S, Helgstrand F, Hjørne F, Bytzer P. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication. World J Gastroenterol 2017; 23(37): 6907-6910 [PMID: 29085234 DOI: 10.3748/wjg.v23.i37.6907]
URL: https://www.wjgnet.com/1007-9327/full/v23/i37/6907.htm
Number Citing Articles
1
R. Kettritz, F. C. Luft. Seltene ElektrolytstörungenDer Nephrologe 2019; 14(2): 94 doi: 10.1007/s11560-018-0278-7
2
嘉豪 李. Common Adverse Reactions and Corresponding Management Measures of Cisplatin Combined with Gemcitabine in ChemotherapyAdvances in Clinical Medicine 2023; 13(12): 19087 doi: 10.12677/ACM.2023.13122684
3
Rohit Tayal, Sabina Yasmin, Samrat Chauhan, Thakur Gurjeet Singh, Monika Saini, Eman Shorog, Maryam M. Althubyani, Baiaan H. Alsaadi, Fatimah Aljohani, Maram A. Alenazi, Sarah A. Abutaily, Mohammad Yousuf Ansari. Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?Pharmaceuticals 2023; 16(10): 1387 doi: 10.3390/ph16101387
4
OmeprazoleReactions Weekly 2018; 1710(1): 244 doi: 10.1007/s40278-018-48916-z
5
Ho Seok Seo, Miyoung Choi, Sang-Yong Son, Min Gyu Kim, Dong-Seok Han, Han Hong Lee. Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018Journal of Gastric Cancer 2018; 18(4): 313 doi: 10.5230/jgc.2018.18.e41
6
Pim M. W. Janssens, Michiel W. Pot, Moniek Wouters, Henk J. van Leeuwen, Marcel M. G. J. van Borren. What extreme laboratory values can be obtained that (some) patients can survive with?Scandinavian Journal of Clinical and Laboratory Investigation 2022; 82(1): 50 doi: 10.1080/00365513.2021.2015800
7
Arun Koyyada. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestationsTherapies 2021; 76(1): 13 doi: 10.1016/j.therap.2020.06.019
8
Jinfeng Zhang, Mingxi Lin, Yizi Jin, Linhan Gu, Ting Li, Baoying Yuan, Biyun Wang, Leiping Wang, Sheng Zhang, Jun Cao, Zhonghua Tao, Jian Zhang, Xichun Hu. Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemiaBreast Cancer Research and Treatment 2020; 182(3): 719 doi: 10.1007/s10549-020-05730-2
9
Paola Cabras, Michele Anedda, Laura Caddeo, Marongiu Francesco, Mameli Antonella. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term TherapyAmerican Journal of Therapeutics 2020; 27(6): e676 doi: 10.1097/MJT.0000000000001041